Thursday, July 31

Advertisement shocks medical fraternity

Mumbai: An ad promising seats in various undergraduate (UG) and postgraduate (PG) medical courses has shocked the medical fraternity. The ad published by a Maharashtra-based medical consultancy claims to help candidates with low NEET scores secure admission, boasting “Grab your seats with a low NEET PG/UG score.” According to the ad, the consultancy offers MD Dermatology seats for Rs 95 lakh, MD General Medicine for Rs 90 lakh, MD Paediatrics for Rs 90 lakh, MD Pulmonology for Rs 80 lakh, MD Psychiatry for Rs 85 lakh, MD Anaesthesia for Rs 70 lakh, MD Pathology for Rs 50 lakh, MD Anatomy for Rs 90 lakh, MS General Surgery for Rs 80 lakh, MS Orthopaedics for Rs 90 lakh, MS Obstetrics and Gynaecology for Rs 95 lakh, MS ENT for Rs 80 lakh, and MS Ophthalmology for Rs 80 lakh.

READ ALSO : Porsche case: Forensic doctor bail plea opposed

Along with the rate chart for UG & PG medical courses, the consultancy lists several services, including form filling, submission, admission assistance, document help, regular counselling updates, college visits, monitoring rounds, and tracking seat cancellations. They urge interested candidates to contact them for free counselling and registration. Social media users reacted strongly to the ad, expressing shock and confusion. Some questioned the legality of openly selling medical seats, while others criticized the system that allows such practices.

Share.
Leave A Reply

Doctors Post is a news portal tailored to provide current news & updates on issues related exclusively to medical & healthcare professionals. The content of Doctor Post is judiciously authored by a dedicated team of legal experts, doctors and reporters.  The intent of the content is to expeditiously update doctor’s information & news necessary for the smooth functioning of their profession.

© 2024 Doctor Post. All Rights Reserved. Created and Maintained by Creative web Solution

Disclaimer: Use of the site is governed by our terms of use, privacy policy, and advertisement policy. For further details, please refer to our Disclaimer.

Exit mobile version